Table 1.

Experimental Groups

Study Group Donor Recipient Treatment of Donor Splenocytes
Control  B6AF1 B6AF1 None  
GVHD  A  B6AF1 None  
Gamma  A B6AF1 2,500 cGy gamma radiation 
PCT  A  B6AF1 150 μmol/L S-59 + 2.1 J/cm2 UVA 
Study Group Donor Recipient Treatment of Donor Splenocytes
Control  B6AF1 B6AF1 None  
GVHD  A  B6AF1 None  
Gamma  A B6AF1 2,500 cGy gamma radiation 
PCT  A  B6AF1 150 μmol/L S-59 + 2.1 J/cm2 UVA 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal